Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease

Fig. 1

Peak anti-recombinant human acid α-glucosidase (anti-rhGAA) antibody titers. a Distribution of peak anti-rhGAA antibody titers, across three groups: low titer (< 1:1250), intermediate titer (1:1,250– < 1:31,25) and high titer (≥ 1:31,250). b Mean and range of anti-rhGAA antibody titer over time for the total group. The number of patients at each time point is indicated. The dotted lines indicate the thresholds between low-intermediate and intermediate-high titers

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172